NAMA joins conservation, fishing, and consumer organizations to comment on the recent Food and Drug Administration’s Draft Guidance on Regulating Genetically Engineered (GE) Animals. The guidance outlines how the FDA plans to use its authority under the New Animal Drug Provisions of the Federal Food Drug and Cosmetic Act (FFDCA) to oversee GE animals, including GE or transgenic fish. Already, species of transgenic fish are being developed around the world; there is at least one pending before FDA for approval, a GE Atlantic salmon designed to grow as much as 10 to 30 times faster than normal salmon. The groups ask the FDA to reject any applications for transgenic fish because of the foreseeable potential negative impacts to human health, the environment, and fishing communities.
FINAL FDA GE Animal Guidance coalition letter for circulation_final_11_18